<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Women & Infants | Company News & Executive Profiles | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/women+%26+infants.html?i=8]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Women & Infants]]></description>
	<s:counts start="0" returned="1" found="1" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Sequenom Announces Launch of RNA-Based Noninvasive Aneuploidy  Study]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_28/ai_n30984707]]></link>
		<description><![CDATA[Independent Study Will Document Performance of SEQureDx T21 Technology for Down Syndrome in 10,000 Pregnant Women  SAN DIEGO -- Sequenom, Inc. (NASDAQ: SQNM) today announced the launch of an independent, prospective, multi-center observational study to document the performance of Sequenom's SEQureDx[TM] Trisomy 21 technology for Down syndrome based upon...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 28 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/women+%2526+infants.html"><![CDATA[Women & Infants]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
